Journal of Ophthalmology / 2012 / Article / Tab 3

Clinical Study

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Table 3

Changes in visual acuity after PDT combined with IVR during 12 months.

Changes in logMAR from the baseline1 month3 months6 months12 months

≧ 0.3 logMAR units improvement7 eyes (18.4%)16 eyes (42.1%)14 eyes (36.8%)15 eyes (39.5%)
Changes under 0.3 logMAR units30 eyes (78.9%)21 eyes (55.3%)23 eyes (60.5%)21 eyes (55.3%)
≧0.3 logMAR units deterioration1 eye (2.6%)1 eye (2.6%)1 eye (2.6%)2 eyes (5.3%)

IVR: intravitreal injection of ranibizumab, PDT: photodynamic therapy.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.